Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HIV data dive: tracking treatment success in sichuan

NCT ID NCT07519538

Knowledge-focused Sponsor: Southwest Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at medical records and follow-up data from 10 people living with HIV in four cities in southern Sichuan, China. The goal is to see how well HIV treatment is working by checking virus levels after 12 months. This is an observational study that does not test a new treatment, but aims to improve understanding of HIV care in the region.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of people living with HIV (PLWH) who receive care at designated HIV treatment institutions across four prefecture-level cities in southern Sichuan Province, China: Luzhou, Zigong, Neijiang, and Yibin. These four cities collectively comprise 23 districts and counties with considerable intra-regional variation in healthcare resources and HIV burden. Participants are recruited from outpatient clinics and community follow-up encounters at the participating study sites. The study employs a consecutive enrolment strategy with quota controls applied by city and age group (\<50, 50-64, ≥65 years) to ensure adequate representation across clinically relevant strata. The ≥65 years age stratum is deliberately oversampled to enable robust subgroup analyses of older adults, who face unique challenges including polypharmacy and age-related comorbidities. The retrospective component includes individuals with historical records from 1 January 2019 to 31 December 2025. The

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * People living with HIV (PLWH) or AIDS patients who are registered and diagnosed at the participating research centers in Luzhou, Zigong, Neijiang, or Yibin, China * Key assessment information (clinical, laboratory, or follow-up data) obtainable during the study period * Traceable medical treatment or follow-up records within the retrospective time window (1 January 2019 to 31 December 2025) * Able to understand and complete the questionnaire and provide written informed consent (for the prospective component) * Residing or visiting within the four southern Sichuan cities, or continuously managed at the local research centers Exclusion Criteria: * Missing key information that cannot be verified or supplemented from original records * Unable to complete the questionnaire and no alternative data collection method available * Obviously inconsistent or untrustworthy data that cannot be confirmed after verification * Not suitable for inclusion under ethical and compliance requirements (e.g., unable to provide consent without a legally authorized representative when required)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (human immunodeficiency virus) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV (human immunodeficiency virus)

Contacts and locations

Locations

  • Southwest Medical University

    Luzhou, Sichuan, 646000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.